Structure Therapeutics (GPCR) - News Mentions

Sign up to add (GPCR) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 50%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Bank of Montreal Can Purchases 3,671 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)
April 18
Alliancebernstein L.P. Sells 16,372 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)
April 15
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
April 14
American Century Companies Inc. Purchases 67,325 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)
April 1
Natixis Advisors LLC Reduces Position in Structure Therapeutics Inc. (NASDAQ:GPCR)
March 28
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $81.29 Consensus Target Price from Brokerages
March 27
Jones Financial Companies Lllp Purchases 971 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)
March 16
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by M&T Bank Corp
March 14
Structure Therapeutics (GPCR) to Release Earnings on Friday
March 11
Oral Proteins & Peptides Market Research Report 2025: Semaglutide, Linaclotide, Calcitonin, GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder Forecast to 2029
April 17
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
April 17
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
April 15
Obesity Market Analysis and Sales Forecasts, 2021-2024 & 2025-2031
March 27
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate
March 19

Month over Month

Est. daily news mentions.

Mar 2025 0
Feb 2025 0
Jan 2025 0

How often is Structure Therapeutics mentioned in the news?

Structure Therapeutics was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Structure Therapeutics performing compared to its industry peers?

Structure Therapeutics underperforms its industry peers when it comes to News Mentions, ranking in the 17th percentile.

Has there been an increase or decrease in news mentions of Structure Therapeutics in the last month?

There has been no significant change in the number of news mentions for Structure Therapeutics' compared to the last month.

Why is it important to track news mentions for Structure Therapeutics?

By monitoring mentions in the news for Structure Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Structure Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Structure Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact